Lung cancer in middle-aged patients

Area of Science:

• Oncology
• Epidemiology
• Medical Research

Background:

• Lung cancer incidence varies across age groups.
• Understanding clinicopathological differences in middle-aged patients is crucial for targeted treatment.
• Previous studies have focused on younger or elderly lung cancer cohorts.

Purpose of the Study:

• To investigate the clinicopathological characteristics of middle-aged lung cancer patients.
• To compare these features with younger and older patient groups.
• To assess survival outcomes in middle-aged lung cancer patients.

Main Methods:

• Retrospective analysis of 1016 consecutive lung cancer patients.
• Categorization of patients into age groups, including middle-aged (40s-50s).
• Evaluation of demographic, pathological, and smoking habit data.

Main Results:

• Middle-aged patients constituted 22.8% of the cohort.
• Adenocarcinoma predominance and a higher female-to-male ratio were observed in middle-aged patients, similar to younger groups.
• Increased smoking prevalence was noted with advancing age groups.
• Middle-aged patients presented with more advanced stages but had comparable survival to younger patients.
• Two distinct subgroups within middle-aged patients mirrored characteristics of younger or elderly cohorts.

Conclusions:

• Middle-aged lung cancer patients exhibit unique epidemiological and pathological profiles.
• Despite advanced disease, middle-aged patients do not experience inferior survival compared to younger individuals.
• The heterogeneity within the middle-aged group suggests distinct underlying disease drivers or treatment responses.